Overview

Global Vaccines Market is estimated to value over USD 64 billion by 2027 end with a CAGR of over 6.8% during the forecast period 2020 to 2027.

The vaccines market growth can be credited to a rise in the occurrence of infectious diseases, increased financial support from the government for developing vaccines, rising emphasis on immunization, increased research and development activities in enhancing the vaccines. Conversely, the requirement of capital investments for the development of vaccines is huge which shall impede the growth of the market.

The market is fragmented into technology, type, disease indication, route of administration, patient type and region. The technology segment is categorised into inactivated and subunit vaccines, conjugate vaccines, recombinant vaccines, live attenuated vaccines, toxoid vaccines and recombinant vaccines. The conjugate vaccines held the largest vaccines market share, and this can be primarily credited to a rise in the support of the government, increase in the investments made by key players in developing conjugate vaccines. Based on the route of administration, the market is fragmented into oral administration, intramuscular and subcutaneous administration and other routes of administration. The intramuscular and subcutaneous administration is predicted to proliferate during the forecast period, and this is mainly due to its capability of providing a lower injection site reaction rate and a good immune response.

Major players included in the Vaccines Market are:    

  • GLAXOSMITHKLINE PLC
  • PFIZER INC.
  • MERCK & CO. INC
  • SANOFI PASTEUR SA
  • CSL LIMITED
  • EMERGENT BIOSOLUTIONS
  • JOHNSON & JOHNSON
  • ASTRAZENECA
  • SERUM INSTITUTE OF INDIA PVT. LTD
  • BAVARIAN NORDIC
  • MITSUBISHI TANABE PHARMA CORP.
  • DAIICHI SANKYO CO. LTD.
  • PANACEA BIOTEC LTD.
  • BIOLOGICAL E LTD.
  • BHARAT BIOTECH

 (Note: The list of the major players will be updated with the latest market scenario and trends)
Vaccines Market
Vaccines Market Segmentation:
By Technology

  • Conjugate Vaccines
  • Inactive and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines

By Type

  • Monovalent Vaccines
  • Multivalent Vaccines

 By Disease Indication

  • Pneumococcal Disease
  • DTP
  • Influenza
  • HPV
  • Meningococcal Disease
  • Polio
  • Hepatitis
  • Rotavirus
  • MMR
  • Varicella
  • Herpes Zoster
  • Others

By Route of Administration

  • Intramuscular and Subcutaneous Administration            
  • Oral Administration
  • Others

 By Patient Type

  • Pediatric Patients               
  • Adult Patients
  • Others

 By Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the world
     

Regional Analysis:
The North America region is predicted to dominate the global market, and this is mainly due to a high occurrence of infectious disorders and rising investments by private and public organizations for developing vaccines and a strong presence of key market players in the region. The Asia Pacific region is expected to project the highest growth and this mainly due to rise in the disposable income leading to an increased healthcare expenditure, increase in the patient pool and growing initiatives by the government.
 

Competitive Landscape:

The prominent market players are GlaxoSmithKline plc., Pfizer, Inc. Merck & Co., Inc., Sanofi Pasteur SA, CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson, Serum Institute of India, AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company, Limited.
 

The Impact of COVID-19 on Vaccines Market:
Major pharmaceutical companies are creating strategic alliances to develop vaccines for treating COVD-19. For instance, Sanofi and GlaxoSmithKline have partnered to launch a vaccine for novel coronavirus during the second half of 2020. Sanofi will use its S-protein antigen that has produced a protein that genetically matches with the protein present on the surface of the novel coronavirus while GlaxoSmithKline will offer their pandemic adjuvant technology, an immunological agent that is added to a vaccine in order to boost its immune response and produce long-lasting immunity and more antibodies. Furthermore, Novavax, a biotechnology company based in USA, is planning to partner with Nucleus Network, an Australian company specialized in clinical trials, to initiate the testing of the NVX-CoV2373 vaccine and this will be the first vaccine for COVID-19 to be tested outside the United States. Novavax previously made efforts in developing vaccines for SARS and MERS. This experience shall assist them in developing a vaccine for COVID-19.    
 

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
     

Objectives of the Study:

  • To provide with an exhaustive analysis on the Vaccines Market By Technology, By Type, By Disease Indication, By Route of Administration, By Patient Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
     

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics